R.PR
REGISTERED-PRINCIPAL REGISTER
06/09/2026
Back to search
Official data from USPTO
XOLREMDI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
06/09/2026
Trademark type
Combined
Nice classes
5
Filing date
11/05/2025
Registration date
06/09/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/09/2026
Last transaction
06/09/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2024-05-00
First use in commerce
2024-05-00
Drawing code
3
Owner type
03
Owner location
Boston, MA, US
Examiner
JOHN, CRISTEL M
Law office
N70
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the wording "XOLREMDI" in stylized font in a gradient of blue and purple. To the left of the wording is a design consisting of three curved lines of small dots forming a spiral-like design, with the dots decreasing in size toward the lower right. The dots appear in shades of orange, purple, and blue. The color white represents background and is not claimed as a feature of the mark.
Holders and representatives
Holders
X4 Pharmaceuticals, Inc.
Representatives
Karen K. Won Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of wartshypogammaglobulinemiainfectionsmyelokathexis (WHIM) syndrome; pharmaceutical preparations for the treatment of immunodeficiencies; pharmaceutical preparations for the treatment of neutropenia
Publications
History of USPTO decisions and trademark events.
19 publications found
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/21/2026
PUBO
PUBLISHED FOR OPPOSITION
04/21/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/15/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/23/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
03/23/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/23/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
03/23/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/23/2026
DOCK
ASSIGNED TO EXAMINER
03/18/2026
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/12/2026
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/12/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/09/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/09/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/09/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/09/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/09/2025
MAFR
APPLICATION FILING RECEIPT MAILED
11/05/2025
NWAP
NEW APPLICATION ENTERED
11/05/2025
Continuous trademark protection
Get notified about every new filing that threatens XOLREMDI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.